Anne Wojcicki's nonprofit wins bid for genetic testing company 23andMe
A nonprofit controlled by Anne Wojcicki, former chief executive of 23andMe, has won the bidding process to buy the bankrupt genetic testing company.
If approved by the court, the sale would put Wojcicki back at the helm of the company she co-founded and previously attempted to take private.
23andMe, which helped popularize at-home DNA test kits and was once valued at $6 billion, declared Chapter 11 bankruptcy in March.
The potential sale of the company has raised questions over privacy standards for genetic data, which experts say is uniquely sensitive, immutable and irreplaceable if stolen.
Read more: 'People should be worried': 23andMe bankruptcy could expose customers' genetic data
More than 11 million customers have given DNA samples to 23andMe, putting a trove of genetic information under the company's control.
Wojcicki's nonprofit TTAM Research Institute agreed to comply with 23andMe's privacy policy and committed to adopting additional consumer protections, according to a 23andMe statement. TTAM has offered $305 million to buy 23andMe and the company's assets.
'I am thrilled that TTAM Research Institute will be able to continue the mission of 23andMe to help people access, understand and benefit from the human genome," Wojcicki said in a statement. "We believe it is critical that individuals are empowered to have choice and transparency with respect to their genetic data."
Read more: States sue to block the sale of genetic data collected by DNA testing company 23andMe
New York-based drug maker Regeneron Pharmaceuticals was poised to buy 23andMe before the bankruptcy judge reopened the bidding process to allow for a bid from TTAM. The final round of bidding was conducted by the U.S. Bankruptcy Court for the Eastern District of Missouri and concluded when Regeneron declined to make a higher bid.
Dozens of states have filed a joint lawsuit against 23andMe to block the South San Francisco-based company's sale of its customers' genetic data without explicit consent.
'This isn't just data — it's your DNA,' said Oregon Atty. Gen. Dan Rayfield in a statement. 'People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest bidder.'
Sign up for our Wide Shot newsletter to get the latest entertainment business news, analysis and insights.
This story originally appeared in Los Angeles Times.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Dr. Sunaina Shrivastava of YellowFryum Inc. Named a 2025 '40 Under 40 Rising Star' for Leadership in Marketing and Academia
WESTCHESTER, NY / / June 15, 2025 / The Business Council of Westchester has named Dr. Sunaina Shrivastava, BEng, MBA, PhD, to its prestigious 2025 "40 Under 40" list. The recognition honors her outstanding leadership and contributions at the intersection of business innovation, strategic marketing, and academia. Dr. Shrivastava is the Co-founder and CEO of YellowFryum Inc., a premier New York-based marketing strategy and growth advisory firm. The company specializes in two verticals: YellowFryum Fin, which serves fintechs and financial institutions by driving investor engagement and retention; and YellowFryum Med, which supports medical aesthetics and healthtech brands through behaviorally informed, compliant digital marketing. Under her leadership, YellowFryum has become a trusted partner for brands that require high-impact, compliance-sensitive marketing - particularly within regulated industries like finance and healthcare. A leading authority inBehavioral Marketing and Growth Strategy, Shrivastava has published academic work in journals such as Journal of Consumer Marketing, Judgment and Decision Making, and Journal of Marketing Communications. She has taught Master's and MBA courses at prestigious institutions including New York University (NYU), Rensselaer Polytechnic Institute (RPI), Manhattan University, and the New Jersey Institute of Technology (NJIT), where she blends academic rigor with real-world application. Her cross-disciplinary contributions were recently highlighted in a cover feature by Brainz Magazine, recognizing her influence at the intersection of marketing innovation, academia, and industry leadership. Outside of her professional endeavors, Dr. Shrivastava is deeply committed to community service. As an active member of Rotary International, she has been awarded the Paul Harris Fellow distinction for her philanthropic impact. She also supports global initiatives like the Rotary-Gates Foundation's PolioPlus program, working toward the eradication of polio as a PolioPlus Society member. The Rising Stars initiative, modeled after the national "40 Under 40" business recognition program, celebrates young professionals who have demonstrated significant entrepreneurial or professional achievement, strong leadership qualities, and active engagement in their fields and communities. "The 2025 class of 40 Under 40 Rising Stars is exceptionally talented, creative, and driven," said Heidi Winslow, Chair of the Rising Stars program and Partner at DelBello Donnellan Weingarten Wise & Wiederkehr, LLP. "They represent a broad spectrum of industries and bring a wealth of experience and fresh perspective. These Rising Stars are the future leaders of Westchester County's business and civic communities. We are thrilled to recognize such an outstanding group." The 2025 honorees will be celebrated at a formal awards ceremony on September 16, 2025, at Million Air, located at Westchester County Airport. For more information about YellowFryum and its services, please visit Company Name: YellowFryum Person: Dr. Sunaina ShrivastavaEmail: shrivastava@ SOURCE: YellowFryum Inc. View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Nets Expected To Make Massive Moves Before 2025 NBA Draft With 4 First-Round Picks And Up To $80 Million In Cap Space
Nets Expected To Make Massive Moves Before 2025 NBA Draft With 4 First-Round Picks And Up To $80 Million In Cap Space originally appeared on Fadeaway World. The Brooklyn Nets are sitting on a goldmine ahead of the 2025 NBA Draft, and the rest of the league knows it. Advertisement According to Grant Hughes of Bleacher Report, the Nets are the team to watch as draft night approaches. Armed with four first-round picks — Nos. 8, 19, 26, and 27 and up to $80 million in cap space, Brooklyn has the tools to reshape the NBA landscape in a matter of days. "Depending on what Brooklyn does with its own free-agent cap holds and qualifying offers, it will have somewhere between $40 and $80 million in room below the cap. That'd be a powerful trade tool in any offseason." "In this one, where nobody else comes anywhere close to that level of financial flexibility, it's like a combination of a magic wand, a skeleton key and the Infinity Gauntlet." "The Nets are all-powerful facilitators, capable of taking on unwanted cash (with picks attached, of course) in order to grease the skids for other teams' exchanges." Advertisement That's not hyperbole. No other franchise comes close to this level of flexibility, financially or in trade assets. Most teams are tangled in luxury tax constraints, struggling to even make minor upgrades. Meanwhile, the Nets can absorb bad contracts, offer pick compensation, or even act as a third-team facilitator. In a summer projected to be movement-heavy, all trade roads may run through Brooklyn. With four picks in the top 30, the Nets could go young and rebuild slowly. But that's not the vibe coming from league insiders. Brooklyn is reportedly eyeing star talent. They're believed to be active in discussions to move up from No. 8 or package picks and players for a ready-made All-Star. One of the names quietly linked to Brooklyn is Giannis Antetokounmpo. Advertisement For the first time, Giannis is exploring options outside of Milwaukee, and the Nets, who are in a major market with young talent and flexibility, have the ability to create a superstar-friendly environment. Though a Giannis trade would be complex and require a bidding war, Brooklyn is among the few that can compete. Another name gaining traction is Jaylen Brown. If the Celtics pivot this summer, possibly due to Jayson Tatum's Achilles injury, Brown could be on the move, and the Nets have enough capital to make a real push. A Brown-Giannis combo? It's ambitious, but Brooklyn is one of the few teams that can credibly pursue that vision. And it's not just about bringing players in. Nicolas Claxton is a free agent and has been linked to the Lakers, among others. He could be a key piece in a trade. Advertisement Cameron Johnson is also drawing interest from several contenders as a high-level 3-and-D wing. The Nets may flip those two for more assets or pair them in larger packages. It's hard to believe it's been less than three years since the Durant-Irving era collapsed. Brooklyn was a laughingstock after that implosion. But now, with a clean financial slate, multiple first-round picks, and an aggressive front office, they may be the biggest power player in the 2025 offseason. Don't be surprised if the Nets go from rebuild to reloaded before draft night is even over. Related: 3 Superstars The Brooklyn Nets Can Target To Be Their Franchise Player This story was originally reported by Fadeaway World on Jun 9, 2025, where it first appeared.
Yahoo
2 hours ago
- Yahoo
Micron Announces $200 Billion US Investment For Domestic Chip Manufacturing, AI Memory Production
Micron Technology Inc. (NASDAQ:MU) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, Micron Technology announced a substantial investment of ~$200 billion to support its US manufacturing and R&D capabilities. This move aligns with President Donald Trump's initiative to boost domestic chip production and reduce reliance on foreign manufacturing. The total investment includes ~$150 billion specifically allocated for domestic manufacturing capacity and another ~$50 billion for R&D. This expanded manufacturing footprint will encompass a second advanced memory fabrication plant in Boise, Idaho (alongside its existing R&D operations), up to 4 leading-edge high-volume fabs in New York, and the expansion & modernization of its existing manufacturing fab in Manassas, Virginia. A close-up view of a computer motherboard with integrated semiconductor chips. A key focus of this investment is to accelerate the development and production of advanced HBM products, which are crucial components in AI data centers. Micron anticipates its initial Idaho plant to begin producing hardware in 2027 and expects to commence ground preparation for its New York facilities later this year. The company aims to produce 40% of its DRAM memory in the US as a result of these investments. Micron Technology Inc. (NASDAQ:MU) designs, develops, manufactures, and sells memory and storage products internationally. The company operates through 4 segments: Compute & Networking Business Unit, Mobile Business Unit, Embedded Business Unit, and Storage Business Unit. While we acknowledge the potential of MU as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
